RenovoRx Q2 EPS $(0.22) Beats $(0.25) Estimate
Portfolio Pulse from Benzinga Newsdesk
RenovoRx (NASDAQ:RNXT) reported Q2 losses of $(0.22) per share, beating the analyst consensus estimate of $(0.25) by 12 percent. This represents a 24.14 percent increase over losses of $(0.29) per share from the same period last year.
August 17, 2023 | 12:39 pm
News sentiment analysis
Sort by:
Descending
POSITIVE IMPACT
RenovoRx's Q2 earnings beat analyst estimates, showing a 24.14% improvement from last year's Q2. This could potentially boost investor confidence in the company.
RenovoRx's Q2 earnings beat analyst estimates, which is generally seen as a positive sign by investors. The fact that the company's losses have decreased by 24.14% compared to the same period last year could also boost investor confidence in the company's financial health and future prospects, potentially leading to an increase in the company's stock price in the short term.
CONFIDENCE 90
IMPORTANCE 75
RELEVANCE 100